Evidence map›Paper›PMID 31988118›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

High-complexity extracellular barcoding using a viral hemagglutinin.

Gavriel Mullokandov, Gayathri Vijayakumar, Paul Leon, Carole Henry, Patrick C Wilson, Florian Krammer, Peter Palese, Brian D Brown

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Gavriel MullokandovPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Gayathri VijayakumarDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0001-8868-8265
Paul LeonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Carole HenryDepartment of Medicine, Section of Rheumatology, Gwen Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, IL 60637.
Patrick C WilsonDepartment of Medicine, Section of Rheumatology, Gwen Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, IL 60637.
Florian KrammerDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Peter PaleseDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; peter.palese@mssm.edu brian.brown@mssm.edu.
Brian D BrownPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029; peter.palese@mssm.edu brian.brown@mssm.edu.
Icahn School of Medicine at Mount Sinai · USUniversity of Chicago · US

Funding

Toward a Universal Influenza Virus VaccineP01AI097092 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AHMED, RAFI · 2012 to 2022
$17.6M
Pro-Codes: A novel vector and cell barcoding technologyR33CA223947 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BROWN, BRIAN D · 2018 to 2020
$1.3M
Antibody responses in humans after infection with avian influenza virusesR01AI128821 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KRAMMER, FLORIAN · 2017 to 2021
$1.0M
NCI NIH HHS R33 CA223947NIAID NIH HHS HHSN272201400008CNIAID NIH HHS P01 AI097092NIAID NIH HHS R01 AI128821
6 · The paper itself

Abstract

While single-cell sequencing technologies have revealed tissue heterogeneity, resolving mixed cellular libraries into cellular clones is essential for many pooled screens and clonal lineage tracing. Fluorescent proteins are limited in number, while DNA barcodes can only be read after cell lysis. To overcome these limitations, we used influenza virus hemagglutinins to engineer a genetically encoded cell-surface protein barcoding system. Using antibodies paired to hemagglutinins carrying combinations of escape mutations, we developed an exponential protein barcoding system which can label 128 clones using seven antibodies. This study provides a proof of principle for a strategy to create protein-level cell barcodes that can be used in vivo in mice to track clonal populations.

Indexed as

AnimalsAntibodies, MonoclonalCell TrackingFemaleFlow CytometryHEK293 CellsHemagglutinin Glycoproteins, Influenza VirusHumansMelanomaMiceMice, Inbred C57BLOrthomyxoviridaeAntibodies, MonoclonalHemagglutinin Glycoproteins, Influenza Viruscell barcodingprotein engineeringvirology

Identifiers

PMID31988118
PMCPMC7022207
OpenAlexW3004029597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.